NA
MNOV icon

NewEdge Advisors’s MediciNova MNOV Stock Holding History

NewEdge Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$4 – 4095
2025
Q1 		$4 Hold
3
– – ﹤0.01% 3924
2024
Q4 		$6 Buy
+3
New +$6 ﹤0.01% 3873
2023
Q3 		– Sell
-8
Closed -$18 – 3583
2023
Q2 		$18 Hold
8
– – ﹤0.01% 3457
2023
Q1 		$17 Hold
8
– – ﹤0.01% 3389
2022
Q4 		$0 Buy
+8
New +$18 ﹤0.01% 4165

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NewEdge Advisors's MNOV Position: Q2 2025 in Review

NewEdge Advisors sold out of MediciNova (MNOV) in Q2 2025, closing a stake of 3 shares — an estimated $4 sold.

NewEdge Advisors first reported a position in MNOV in Q4 2022 and held it in 5 quarters. The position peaked at $18 in Q2 2023. 23 funds tracked by Wall St. Rank hold MNOV as of Q2 2025.

  • NewEdge Advisors reported no remaining MediciNova position as of Q2 2025 after selling out during the quarter.
  • NewEdge Advisors sold 3 MediciNova shares in Q2 2025, an estimated $4.
  • NewEdge Advisors first reported a position in MediciNova in Q4 2022 and held it in 5 quarters.
  • NewEdge Advisors's MediciNova position peaked at $18 in Q2 2023.
  • 23 funds tracked by Wall St. Rank held MediciNova as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.